Stem cell therapy for retinal diseases

doi:10.4252/wjsc.v7.i1.160

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3717)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-1) series.

Item

Count

PDF

377

WORD

218

HTML

3009

Tables (1-1)

113

Sum=3717

Jan 26, 2015 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Stem Cells. Jan 26, 2015; 7(1): 160-164
Published online Jan 26, 2015. doi: 10.4252/wjsc.v7.i1.160

Stem cell therapy for retinal diseases

José Mauricio Garcia, Luisa Mendonça, Rodrigo Brant, Murilo Abud, Caio Regatieri, Bruno Diniz

José Mauricio Garcia, Luisa Mendonça, Murilo Abud, Bruno Diniz, Department of Ophthalmology, Universidade Federal de Goiás, Goiânia 74001-970, Brazil

Rodrigo Brant, Caio Regatieri, Bruno Diniz, Department of Ophthalmology, Universidade Federal de São Paulo, São Paulo 04023-062, Brazil

Author contributions: All authors contributed to this paper.

Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Correspondence to: Bruno Diniz, MD, PhD, Department of Ophthalmology, Universidade Federal de Goiás, Al. Ricardo Paranhos, 799, Goiânia 74001-970, Brazil. dinizb@me.com

Telephone: +55-62-35211000

Received: July 29, 2014
Peer-review started: July 29, 2014
First decision: August 14, 2014
Revised: September 26, 2014
Accepted: October 14, 2014
Article in press: December 16, 2014
Published online: January 26, 2015

Core Tip

Core tip: The stem cell (SC) retinal therapy has turned into an potentially useful way of treating blinding disorders, such as, Stargadt’s dystrophy, and geographic atrophy. The Food and Drug Administration’s approval for clinical trials using SC retinal therapy, and its good results, may appoint to future promising outcomes, providing an anatomical restoration of the retina, and a functional improval of visual function of several patients.